Cargando…

Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report

PURPOSE: To report a case of recurrent ocular inflammation after optimal therapy of bilateral syphilitic panuveitis responding to oral celecoxib. METHODS: A case report was conducted. RESULTS: A 76-year-old man presented with painful blurry vision in both eyes. Ocular examination disclosed bilateral...

Descripción completa

Detalles Bibliográficos
Autores principales: Suelves, Ana M., Martinez-Castillo, Sebastián, Salavert, Miguel, Díaz-Llopis, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223351/
https://www.ncbi.nlm.nih.gov/pubmed/21785853
http://dx.doi.org/10.1007/s12348-011-0031-0
_version_ 1782217284444487680
author Suelves, Ana M.
Martinez-Castillo, Sebastián
Salavert, Miguel
Díaz-Llopis, Manuel
author_facet Suelves, Ana M.
Martinez-Castillo, Sebastián
Salavert, Miguel
Díaz-Llopis, Manuel
author_sort Suelves, Ana M.
collection PubMed
description PURPOSE: To report a case of recurrent ocular inflammation after optimal therapy of bilateral syphilitic panuveitis responding to oral celecoxib. METHODS: A case report was conducted. RESULTS: A 76-year-old man presented with painful blurry vision in both eyes. Ocular examination disclosed bilateral panuveitis. Serological testing confirmed blood and cerebrospinal fluid syphilitic involvement. After 2 weeks of intravenous penicillin therapy, recurrent episodic sclerouveitis was observed. CONCLUSION: Ocular inflammation after healing of infectious uveitis is a rare ophthalmic sequela. In an immunocompetent patient, either re-infection or immune uveitis should be evoked. Non-steroidal therapeutic options, as celecoxib, could be a good option of treatment in such immune cases.
format Online
Article
Text
id pubmed-3223351
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-32233512011-12-27 Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report Suelves, Ana M. Martinez-Castillo, Sebastián Salavert, Miguel Díaz-Llopis, Manuel J Ophthalmic Inflamm Infect Brief Report PURPOSE: To report a case of recurrent ocular inflammation after optimal therapy of bilateral syphilitic panuveitis responding to oral celecoxib. METHODS: A case report was conducted. RESULTS: A 76-year-old man presented with painful blurry vision in both eyes. Ocular examination disclosed bilateral panuveitis. Serological testing confirmed blood and cerebrospinal fluid syphilitic involvement. After 2 weeks of intravenous penicillin therapy, recurrent episodic sclerouveitis was observed. CONCLUSION: Ocular inflammation after healing of infectious uveitis is a rare ophthalmic sequela. In an immunocompetent patient, either re-infection or immune uveitis should be evoked. Non-steroidal therapeutic options, as celecoxib, could be a good option of treatment in such immune cases. Springer-Verlag 2011-07-22 /pmc/articles/PMC3223351/ /pubmed/21785853 http://dx.doi.org/10.1007/s12348-011-0031-0 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Brief Report
Suelves, Ana M.
Martinez-Castillo, Sebastián
Salavert, Miguel
Díaz-Llopis, Manuel
Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report
title Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report
title_full Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report
title_fullStr Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report
title_full_unstemmed Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report
title_short Celecoxib for recurrent sclerouveitis after syphilitic panuveitis. A case report
title_sort celecoxib for recurrent sclerouveitis after syphilitic panuveitis. a case report
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223351/
https://www.ncbi.nlm.nih.gov/pubmed/21785853
http://dx.doi.org/10.1007/s12348-011-0031-0
work_keys_str_mv AT suelvesanam celecoxibforrecurrentsclerouveitisaftersyphiliticpanuveitisacasereport
AT martinezcastillosebastian celecoxibforrecurrentsclerouveitisaftersyphiliticpanuveitisacasereport
AT salavertmiguel celecoxibforrecurrentsclerouveitisaftersyphiliticpanuveitisacasereport
AT diazllopismanuel celecoxibforrecurrentsclerouveitisaftersyphiliticpanuveitisacasereport